دورية أكاديمية

MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.

التفاصيل البيبلوغرافية
العنوان: MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
المؤلفون: DeBerge M; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Yeap XY; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Dehn S; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Zhang S; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Grigoryeva L; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Misener S; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Procissi D; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Zhou X; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Lee DC; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Muller WA; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Luo X; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Rothlin C; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Tabas I; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.)., Thorp EB; From the Department of Pathology and Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL (M.D., X.Y.Y., S.D., S.Z., L.G., S.M., D.P., X.Z., D.C.Le., W.A.M., X.L., E.B.T.); Division of Molecular Medicine at Columbia University, New York (I.T.); and Department of Immunobiology, School of Medicine, Yale University (C.R.). ebthorp@northwestern.edu.
المصدر: Circulation research [Circ Res] 2017 Sep 29; Vol. 121 (8), pp. 930-940. Date of Electronic Publication: 2017 Aug 29.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4571 (Electronic) Linking ISSN: 00097330 NLM ISO Abbreviation: Circ Res Subsets: MEDLINE
أسماء مطبوعة: Publication: Baltimore, MD : Lippincott Williams & Wilkins
Original Publication: Baltimore, Md. Grune & Stratton.
مواضيع طبية MeSH: Macrophages/*enzymology , Myocardial Reperfusion Injury/*enzymology , Myocardium/*enzymology , Proto-Oncogene Proteins/*metabolism , Receptor Protein-Tyrosine Kinases/*metabolism , ST Elevation Myocardial Infarction/*enzymology, Animals ; Apoptosis ; Cytokines/immunology ; Cytokines/metabolism ; Disease Models, Animal ; Female ; Genetic Predisposition to Disease ; Histocompatibility Antigens Class II/immunology ; Histocompatibility Antigens Class II/metabolism ; Humans ; Immunity, Innate ; Macrophages/immunology ; Macrophages/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Monocytes/enzymology ; Monocytes/immunology ; Myocardial Reperfusion Injury/immunology ; Myocardial Reperfusion Injury/pathology ; Myocardial Reperfusion Injury/physiopathology ; Myocardium/immunology ; Myocardium/pathology ; Phagocytosis ; Phenotype ; Proteolysis ; Proto-Oncogene Proteins/deficiency ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/immunology ; Receptor Protein-Tyrosine Kinases/deficiency ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/immunology ; Receptors, CCR2/genetics ; Receptors, CCR2/immunology ; Receptors, CCR2/metabolism ; ST Elevation Myocardial Infarction/immunology ; ST Elevation Myocardial Infarction/pathology ; ST Elevation Myocardial Infarction/physiopathology ; Signal Transduction ; Time Factors ; c-Mer Tyrosine Kinase
مستخلص: Rationale: Clinical benefits of reperfusion after myocardial infarction are offset by maladaptive innate immune cell function, and therapeutic interventions are lacking.
Objective: We sought to test the significance of phagocytic clearance by resident and recruited phagocytes after myocardial ischemia reperfusion.
Methods and Results: In humans, we discovered that clinical reperfusion after myocardial infarction led to significant elevation of the soluble form of MerTK (myeloid-epithelial-reproductive tyrosine kinase; ie, soluble MER), a critical biomarker of compromised phagocytosis by innate macrophages. In reperfused mice, macrophage Mertk deficiency led to decreased cardiac wound debridement, increased infarct size, and depressed cardiac function, newly implicating MerTK in cardiac repair after myocardial ischemia reperfusion. More notably, Mertk(CR ) mice, which are resistant to cleavage, showed significantly reduced infarct sizes and improved systolic function. In contrast to other cardiac phagocyte subsets, resident cardiac MHCII LO CCR2 - (major histocompatibility complex II/C-C motif chemokine receptor type 2) macrophages expressed higher levels of MerTK and, when exposed to apoptotic cells, secreted proreparative cytokines, including transforming growth factor-β. Mertk deficiency compromised the accumulation of MHCII LO phagocytes, and this was rescued in Mertk(CR ) mice. Interestingly, blockade of CCR2-dependent monocyte infiltration into the heart reduced soluble MER levels post-ischemia reperfusion.
Conclusions: Our data implicate monocyte-induced MerTK cleavage on proreparative MHCII LO cardiac macrophages as a novel contributor and therapeutic target of reperfusion injury.
(© 2017 American Heart Association, Inc.)
References: Inflamm Allergy Drug Targets. 2007 Jun;6(2):101-7. (PMID: 17692033)
Nat Rev Immunol. 2008 May;8(5):327-36. (PMID: 18421305)
Nat Biotechnol. 2011 Oct 09;29(11):1005-10. (PMID: 21983520)
Nature. 2001 May 10;411(6834):207-11. (PMID: 11346799)
Nat Immunol. 2014 Oct;15(10 ):920-8. (PMID: 25194421)
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23 ):6526-31. (PMID: 27199481)
Immunity. 2012 Dec 14;37(6):1076-90. (PMID: 23219392)
Circ Res. 2014 May 9;114(10):1611-22. (PMID: 24625784)
Heart. 2016 Mar;102(5):341-8. (PMID: 26674987)
J Am Coll Cardiol. 2010 Nov 23;56(22):1847-57. (PMID: 21087715)
Circulation. 2016 Mar 1;133(9):826-39. (PMID: 26819373)
J Mol Cell Cardiol. 2014 Nov;76:169-71. (PMID: 25218305)
Apoptosis. 2010 Sep;15(9):1124-36. (PMID: 20552278)
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16029-34. (PMID: 25349429)
Immunity. 2014 Jan 16;40(1):91-104. (PMID: 24439267)
Immunol Rev. 2016 Jan;269(1):44-59. (PMID: 26683144)
Nature. 2011 Aug 21;477(7363):220-4. (PMID: 21857682)
J Clin Invest. 1998 Feb 15;101(4):890-8. (PMID: 9466984)
Annu Rev Physiol. 2010;72:19-44. (PMID: 20148665)
Eur Heart J. 2017 Jan 14;38(3):187-197. (PMID: 28158426)
J Cardiovasc Pharmacol. 2014 Mar;63(3):185-95. (PMID: 24072174)
J Clin Invest. 2017 Feb 1;127(2):564-568. (PMID: 28067670)
Science. 2017 Jun 9;356(6342):1072-1076. (PMID: 28495875)
Am J Pathol. 2007 Nov;171(5):1713-23. (PMID: 17872973)
J Exp Med. 2017 May 1;214(5):1281-1296. (PMID: 28432199)
Am J Surg. 1992 Sep;164(3):248-53. (PMID: 1415924)
Circ Res. 2013 Sep 27;113(8):1004-12. (PMID: 23836795)
Am J Pathol. 2004 Aug;165(2):439-47. (PMID: 15277218)
J Mol Cell Cardiol. 2015 Jul;84:24-35. (PMID: 25870158)
Nat Med. 2011 Nov 07;17(11):1391-401. (PMID: 22064429)
J Biol Chem. 2011 Sep 23;286(38):33335-44. (PMID: 21828049)
Sci Transl Med. 2014 Jan 15;6(219):219ra7. (PMID: 24431111)
Hepatology. 2009 Jul;50(1):185-97. (PMID: 19441102)
Blood. 2007 Feb 1;109 (3):1026-33. (PMID: 17047157)
J Exp Med. 2007 Nov 26;204(12):3037-47. (PMID: 18025128)
Immunity. 2014 Mar 20;40(3):315-27. (PMID: 24656045)
Circ Res. 2009 Jan 30;104(2):e9-18. (PMID: 19096025)
Nature. 1976 May 27;261(5558):319-21. (PMID: 1272406)
Science. 2013 Jan 11;339(6116):166-72. (PMID: 23307734)
N Engl J Med. 2007 Sep 13;357(11):1121-35. (PMID: 17855673)
Circulation. 2013 May 21;127(20):2038-46. (PMID: 23616627)
J Leukoc Biol. 2015 Sep;98 (3):423-34. (PMID: 26019295)
J Exp Med. 2012 Jan 16;209(1):123-37. (PMID: 22213805)
معلومات مُعتمدة: R01 HL064774 United States HL NHLBI NIH HHS; R01 HL046849 United States HL NHLBI NIH HHS; F32 HL127958 United States HL NHLBI NIH HHS; R25 GM079300 United States GM NIGMS NIH HHS; R01 HL122309 United States HL NHLBI NIH HHS; T32 GM008061 United States GM NIGMS NIH HHS; R01 HL132412 United States HL NHLBI NIH HHS; UL1 TR001422 United States TR NCATS NIH HHS; R01 HL127464 United States HL NHLBI NIH HHS; R01 HL075662 United States HL NHLBI NIH HHS; R01 AI089824 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: efferocytosis; inflammation; ischemia reperfusion injury; macrophage; phagocytosis
المشرفين على المادة: 0 (Ccr2 protein, mouse)
0 (Cytokines)
0 (Histocompatibility Antigens Class II)
0 (Proto-Oncogene Proteins)
0 (Receptors, CCR2)
EC 2.7.10.1 (MERTK protein, human)
EC 2.7.10.1 (Mertk protein, mouse)
EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)
EC 2.7.10.1 (c-Mer Tyrosine Kinase)
تواريخ الأحداث: Date Created: 20170831 Date Completed: 20171010 Latest Revision: 20190111
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC5623080
DOI: 10.1161/CIRCRESAHA.117.311327
PMID: 28851810
قاعدة البيانات: MEDLINE
الوصف
تدمد:1524-4571
DOI:10.1161/CIRCRESAHA.117.311327